Resistance the film: Join L.V. Anderson and Slate for a screening and panel discussion.

Talk Superbugs and the Crazy World of Antibiotics With L.V. Anderson at a Screening of Resistance

Talk Superbugs and the Crazy World of Antibiotics With L.V. Anderson at a Screening of Resistance

The inner workings of Slate.
May 5 2014 10:04 AM

Resistance

Join L.V. Anderson for a screening and panel discussion of the film.

Resistance.
Resistance.

Screenshot via Uji Films/Vimeo

Join L.V. Anderson for an evening devoted to superbugs with the screening and discussion of the film Resistance. This film traces the history of mass-produced antibiotics from when they were first introduced in the 1940s and looks at the impact that these powerful drugs have had over the past 70 years on everything from agriculture to the armed forces to resistant infections, which sicken 2 million Americans each year.

Date: May 21, 2014
Time: 6:30 p.m.
Location: Landmark Sunshine Cinema, 143 East Houston St., New York City
Tickets: Free with an RSVP by May 20, and premium seating available to Slate Plus members.

Join us for a reception where you can meet the filmmakers at 6:30 p.m. followed by the screening, which will start at 7 p.m. After the film, stay for a lively and thoughtful panel discussion moderated by L.V. Anderson with filmmaker Michael Graziano; Dr. Martin Blaser, director of the NYU Human Microbiome Program; and Urvashi Rangan, executive director of the Consumer Reports Food Safety and Sustainability Center. This event is open to all Slate Readers. Please send an RSVP email and state the total number in your party.

Advertisement

If you are a Slate Plus member, you will receive priority seating. To RSVP as a Slate Plus member, use the upcoming events tool in the Slate Plus dashboard on the right side of the Slate Plus home page. Your individualized discount code must be included in the RSVP email.

If you’d like to become a Slate Plus member, click here.

Seating is limited.

The film is brought to you by UJI Films in association with the Pew Charitable Trusts, Applegate, and Slate.